Amgen Enterprise Value:
80.80B for May 22, 2013Amgen Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 22, 2013 | 80.80B |
| May 21, 2013 | 80.80B |
| May 20, 2013 | 79.25B |
| May 17, 2013 | 81.84B |
| May 16, 2013 | 81.35B |
| May 15, 2013 | 83.18B |
| May 14, 2013 | 83.57B |
| May 13, 2013 | 82.79B |
| May 10, 2013 | 82.66B |
| May 9, 2013 | 81.04B |
| May 8, 2013 | 81.42B |
| May 7, 2013 | 80.96B |
| May 6, 2013 | 81.24B |
| May 3, 2013 | 82.48B |
| May 2, 2013 | 81.81B |
| May 1, 2013 | 81.02B |
| April 30, 2013 | 80.78B |
| April 29, 2013 | 82.62B |
| April 26, 2013 | 83.90B |
| April 25, 2013 | 84.11B |
| April 24, 2013 | 81.32B |
| April 23, 2013 | 87.15B |
| April 22, 2013 | 87.64B |
| April 19, 2013 | 86.11B |
| April 18, 2013 | 83.17B |
| April 17, 2013 | 84.66B |
| April 16, 2013 | 85.71B |
| April 15, 2013 | 83.94B |
| April 12, 2013 | 86.25B |
| April 11, 2013 | 83.74B |
| April 10, 2013 | 83.77B |
| April 9, 2013 | 80.80B |
| April 8, 2013 | 81.40B |
| April 5, 2013 | 80.61B |
| April 4, 2013 | 81.99B |
| April 3, 2013 | 81.19B |
| April 2, 2013 | 82.38B |
| April 1, 2013 | 79.31B |
| March 28, 2013 | 79.19B |
| March 27, 2013 | 77.42B |
| March 26, 2013 | 76.31B |
| March 25, 2013 | 74.92B |
| March 22, 2013 | 74.74B |
| March 21, 2013 | 73.05B |
| March 20, 2013 | 72.86B |
| March 19, 2013 | 71.62B |
| March 18, 2013 | 70.12B |
| March 15, 2013 | 71.18B |
| March 14, 2013 | 71.46B |
| March 13, 2013 | 70.98B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
AMGN Enterprise Value Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 243.06B |
| Celgene Corporation | 51.12B |
| Pfizer | 212.11B |
AMGN Enterprise Value Rankings
| Overall |
98th percentile 99 of 8005 |
| Sector |
98th percentile 9 of 686 in Healthcare |
| Industry |
98th percentile 3 of 248 in Biotechnology |
AMGN Enterprise Value Range, Past 5 Years
| Minimum | 39.36B | Aug 10 2011 |
| Maximum | 87.64B | Apr 22 2013 |
| Average | 56.08B |
AMGN News
Seeking Alpha May 21